Taiwan
· Delayed Price · Currency is TWD Onyx Healthcare Statistics
Total Valuation
Onyx Healthcare has a market cap or net worth of TWD 4.74 billion. The enterprise value is 4.59 billion.
| Market Cap | 4.74B |
| Enterprise Value | 4.59B |
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | Aug 1, 2024 |
Share Statistics
Onyx Healthcare has 39.01 million shares outstanding. The number of shares has increased by 0.29% in one year.
| Current Share Class | 39.01M |
| Shares Outstanding | 39.01M |
| Shares Change (YoY) | +0.29% |
| Shares Change (QoQ) | -0.46% |
| Owned by Insiders (%) | 12.00% |
| Owned by Institutions (%) | 0.03% |
| Float | 12.26M |
Valuation Ratios
The trailing PE ratio is 34.41.
| PE Ratio | 34.41 |
| Forward PE | n/a |
| PS Ratio | 3.72 |
| PB Ratio | 2.95 |
| P/TBV Ratio | 2.97 |
| P/FCF Ratio | 152.11 |
| P/OCF Ratio | 112.00 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 31.11, with an EV/FCF ratio of 147.43.
| EV / Earnings | 33.41 |
| EV / Sales | 3.60 |
| EV / EBITDA | 31.11 |
| EV / EBIT | 35.96 |
| EV / FCF | 147.43 |
Financial Position
The company has a current ratio of 2.78, with a Debt / Equity ratio of 0.11.
| Current Ratio | 2.78 |
| Quick Ratio | 1.79 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 2.17 |
| Debt / FCF | 5.52 |
| Interest Coverage | 12.86 |
Financial Efficiency
Return on equity (ROE) is 8.63% and return on invested capital (ROIC) is 2.08%.
| Return on Equity (ROE) | 8.63% |
| Return on Assets (ROA) | 1.72% |
| Return on Invested Capital (ROIC) | 2.08% |
| Return on Capital Employed (ROCE) | 3.27% |
| Revenue Per Employee | 10.63M |
| Profits Per Employee | 1.15M |
| Employee Count | 120 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 3.07 |
Taxes
In the past 12 months, Onyx Healthcare has paid 18.11 million in taxes.
| Income Tax | 18.11M |
| Effective Tax Rate | 11.64% |
Stock Price Statistics
The stock price has decreased by -28.90% in the last 52 weeks. The beta is 0.34, so Onyx Healthcare's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | -28.90% |
| 50-Day Moving Average | 123.93 |
| 200-Day Moving Average | 154.36 |
| Relative Strength Index (RSI) | 47.66 |
| Average Volume (20 Days) | 37,255 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Onyx Healthcare had revenue of TWD 1.28 billion and earned 137.50 million in profits. Earnings per share was 3.53.
| Revenue | 1.28B |
| Gross Profit | 434.74M |
| Operating Income | 59.35M |
| Pretax Income | 155.54M |
| Net Income | 137.50M |
| EBITDA | 74.51M |
| EBIT | 59.35M |
| Earnings Per Share (EPS) | 3.53 |
Balance Sheet
The company has 326.34 million in cash and 172.14 million in debt, giving a net cash position of 154.20 million or 3.95 per share.
| Cash & Cash Equivalents | 326.34M |
| Total Debt | 172.14M |
| Net Cash | 154.20M |
| Net Cash Per Share | 3.95 |
| Equity (Book Value) | 1.61B |
| Book Value Per Share | 40.94 |
| Working Capital | 517.97M |
Cash Flow
In the last 12 months, operating cash flow was 42.33 million and capital expenditures -11.16 million, giving a free cash flow of 31.16 million.
| Operating Cash Flow | 42.33M |
| Capital Expenditures | -11.16M |
| Free Cash Flow | 31.16M |
| FCF Per Share | 0.80 |
Margins
Gross margin is 34.07%, with operating and profit margins of 4.65% and 10.78%.
| Gross Margin | 34.07% |
| Operating Margin | 4.65% |
| Pretax Margin | 12.19% |
| Profit Margin | 10.78% |
| EBITDA Margin | 5.84% |
| EBIT Margin | 4.65% |
| FCF Margin | 2.44% |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 3.27%.
| Dividend Per Share | 4.00 |
| Dividend Yield | 3.27% |
| Dividend Growth (YoY) | 15.01% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 121.88% |
| Buyback Yield | -0.29% |
| Shareholder Yield | 2.97% |
| Earnings Yield | 2.90% |
| FCF Yield | 0.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 1, 2024. It was a forward split with a ratio of 1.1499016.
| Last Split Date | Aug 1, 2024 |
| Split Type | Forward |
| Split Ratio | 1.1499016 |
Scores
Onyx Healthcare has an Altman Z-Score of 9.03 and a Piotroski F-Score of 5.
| Altman Z-Score | 9.03 |
| Piotroski F-Score | 5 |